Skip to main content

Advertisement

Figure 1 | Molecular Cancer

Figure 1

From: Inhibition of HSP27 alone or in combination with pAKT inhibition as therapeutic approaches to target SPARC-induced glioma cell survival

Figure 1

SPARC does not enhance or suppress radiation therapy (RT). A. Representative fluorescent images of control C1.1 GFP- and H2 SPARC-GFP-expressing clonogenic colonies (×40 magnification). B. Average colony forming efficiency ± SD of untreated C1.1 and H2 cells (left panel). Average surviving fraction ± SD of C1.1 and H2 cells exposed to 0 or 1-5 Gy (middle panel) or 0, 5 or 10 Gy (right panel), plating 3000 cells/60-mm dish. Plating 1000 cells/60-mm dish gave similar results. C. Average colony forming efficiency ± SD of untreated LN443 cells transfected with control (Csi) or SPARC siRNA (SPARCsi) (left panel). Average surviving fraction ± SD of LN443 cells transfected with Csi or SPARCsi exposed to 0, 5 or 10 Gy (right panel) plating 750 cells/60-mm dish. Plating 1500 cells/60-mm dish gave similar results.

Back to article page